Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

RUBIN DANIEL L. MD; MULLER, HOLDE H. MS; YOUNG, STUART W. MD; HUNKE, WILLIAM A. PhD; GORMAN, WILLIAM G. PhD
Investigative Radiology: January 1994
Announcements: PDF Only
Buy

RATIONALE AND OBJECTIVES

Magnetically susceptible iron oxide (MSIO) contrast agents for magnetic resonance imaging (MRI) of the gastrointestinal (GI) tract are limited because they produce magnetic susceptibility artifacts. To determine whether oral magnetic particles (WIN 39996) can be an effective MRI contrast agent without producing induced image artifacts, we optimized a liquid formulation of WIN 39996.

METHODS

A range of concentrations (25–250 μg iron/mL) and viscosities (1–600 cP) was imaged in a phantom at 1.5 T using conventional spin- echo and gradient-recalled echo pulse sequences. Some formulations also contained titanium.

RESULTS

All concentrations of WIN 39996 at 1 cP produced susceptibility artifacts. For formulations in the 150 to 600 cP range, the 125 to 150 μg/mL concentrations produced signal blackening and magnetic susceptibility image distortion comparable to an air control. Concentrations greater than 150 μg/mL were unacceptable because they produced significant susceptibility artifacts, while concentrations less than 125 μg/mL were undesirable because they produced insufficient signal blackening.

CONCLUSIONS

These preliminary in-vitro studies suggest that an optimized liquid formulation of WIN 39996 can be produced that yields excellent negative contrast without producing image artifacts.

© Lippincott-Raven Publishers.